Keyphrases
Tumor Necrosis Factor-α
100%
Phosphoinositide 3-kinase (PI3K)
100%
Lactobacillus Acidophilus
100%
NF-B
100%
Intestinal Epithelial Cells
100%
Endothelial Junctions
100%
Toll-like Receptor 2 (TLR2)
100%
Inflammatory Bowel Disease
37%
Myosin Light Chain Kinase
25%
Pathway Activation
25%
Cell Culture
12%
Signaling Pathway
12%
Phosphorylation
12%
Health Benefits
12%
Mechanism of Action
12%
Kinase Activity
12%
Wide-ranging
12%
Potential Therapeutics
12%
Protective Effect
12%
Intracellular Signaling
12%
Immune Cells
12%
Inflammatory Cytokines
12%
Beneficial Effects
12%
Probiotic Bacteria
12%
Therapeutic Efficacy
12%
Gastrointestinal Diseases
12%
Induced Activation
12%
Immunopathology
12%
Intestinal Cells
12%
Animal Model System
12%
Gene Activity
12%
Inflammatory Disorders
12%
Myeloid Differentiation Factor 88 (MyD88)
12%
Therapeutic Effect
12%
Metabolic Disorders
12%
MyD88-dependent
12%
Intestinal Tight Junction
12%
Tight Junction Barrier
12%
Caco-2 Cell Monolayer
12%
Inflammatory Bowel Disease Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphatidylinositol 3 Kinase
100%
Tumor Necrosis Factor
100%
Toll Like Receptor 2
100%
Lactobacillus acidophilus
100%
Inflammatory Bowel Disease
57%
Combination Therapy
28%
Myeloid Differentiation Factor 88
28%
Myosin Light Chain Kinase
28%
Side Effect
14%
Phosphotransferase
14%
Cell Culture
14%
Cytokine
14%
Biological Product
14%
Tumor Necrosis Factor Antibody
14%
Therapeutic Effect
14%
Immunopathology
14%
Biochemistry, Genetics and Molecular Biology
Phosphoinositide 3-Kinase
100%
Tumor Necrosis Factor
100%
TLR2
100%
Lactobacillus acidophilus
100%
Myosin Light-Chain Kinase
25%
Kinase
12%
Phosphotransferase
12%
Cell Culture
12%
Intracellular Signaling
12%
Animal Model
12%
Immunocompetent Cell
12%
Proinflammatory Cytokine
12%